{"recordsFiltered":50704,"recordsTotal":50704,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=sponsor__name&start=49500","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=sponsor__name&start=48900","results":[{"registry_id":"NCT06899126","publication_url":"https://clinicaltrials.gov/study/NCT06899126","title":"A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan in Combination With Pembrolizumab Versus Platinum-based Chemotherapy in Combination With Pembrolizumab, as First-line Therapy in Participants With Locally Advanced Unresectable or Metastatic HER2 Overexpressing and PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer (DESTINY-Lung06)","has_exemption":false,"start_date":"2025-10-24","completion_date":"2030-04-24","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07707895","publication_url":"https://clinicaltrials.gov/study/NCT07707895","title":"A Phase Ib/II, Open-label, Safety and Tolerability Trial of Obrixtamig in Combination With ZL-1310 in Patients With Poorly Differentiated NEC","has_exemption":false,"start_date":"2026-10-19","completion_date":"2030-04-26","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07153497","publication_url":"https://clinicaltrials.gov/study/NCT07153497","title":"A Randomized Phase 2 Trial of Olutasidenib-Based Therapies in Patients With Newly Diagnosed IDH1-Mutant Myeloid Malignancies: A MyeloMATCH Substudy","has_exemption":false,"start_date":"2026-11-27","completion_date":"2030-04-26","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566377","publication_url":"https://clinicaltrials.gov/study/NCT07566377","title":"Cord Blood Transplantation in Children and Young Adults With Hematologic Malignancies","has_exemption":false,"start_date":"2026-04-28","completion_date":"2030-04-28","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03547973","publication_url":"https://clinicaltrials.gov/study/NCT03547973","title":"A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer","has_exemption":false,"start_date":"2018-08-13","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04806854","publication_url":"https://clinicaltrials.gov/study/NCT04806854","title":"A Single-Center, Randomized, Open-Label, Parallel Arm Study of Daily Oral LUM-201 in Naive-to-Treatment, Prepubertal Children With Idiopathic Pediatric Growth Hormone Deficiency (PGHD)","has_exemption":false,"start_date":"2021-07-14","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Lumos Pharma","sponsor_slug":"lumos-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06012240","publication_url":"https://clinicaltrials.gov/study/NCT06012240","title":"A Phase 3 Randomized, Placebo-controlled, Double-blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Severe Alopecia Areata","has_exemption":false,"start_date":"2023-10-11","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05919108","publication_url":"https://clinicaltrials.gov/study/NCT05919108","title":"Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers","has_exemption":false,"start_date":"2024-06-11","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06322108","publication_url":"https://clinicaltrials.gov/study/NCT06322108","title":"Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)","has_exemption":false,"start_date":"2024-06-13","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Immune Oncology Research Institute","sponsor_slug":"immune-oncology-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06547216","publication_url":"https://clinicaltrials.gov/study/NCT06547216","title":"A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AOC 1020 Administered Intravenously to Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)","has_exemption":false,"start_date":"2024-07-25","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Avidity Biosciences, Inc.","sponsor_slug":"avidity-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06721689","publication_url":"https://clinicaltrials.gov/study/NCT06721689","title":"A Phase 1/2 Clinical Trial of the Novel Topoisomerase I Inhibitor PEEL-224 as a Single Agent and in Combination With Vincristine and Temozolomide in Children With Refractory, Progressive or Relapsed Solid Tumors","has_exemption":false,"start_date":"2025-03-23","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Theodore Laetsch","sponsor_slug":"theodore-laetsch","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06861920","publication_url":"https://clinicaltrials.gov/study/NCT06861920","title":"Targeting Interindividual Variability in NSAID Responses to Mitigate Chronic Pelvic Pain Risk in Dysmenorrhea (NSAID HEAL)","has_exemption":false,"start_date":"2025-04-07","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Endeavor Health","sponsor_slug":"endeavor-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06884423","publication_url":"https://clinicaltrials.gov/study/NCT06884423","title":"Infant Survival and Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial","has_exemption":false,"start_date":"2025-04-07","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Holly L Hedrick, MD","sponsor_slug":"holly-l-hedrick-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06892678","publication_url":"https://clinicaltrials.gov/study/NCT06892678","title":"DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma","has_exemption":false,"start_date":"2025-04-07","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06702033","publication_url":"https://clinicaltrials.gov/study/NCT06702033","title":"Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: \"The Minimalist Trial-2 (MINT-2)\"","has_exemption":false,"start_date":"2025-04-10","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06946576","publication_url":"https://clinicaltrials.gov/study/NCT06946576","title":"Infant Survival and Long-term Outcomes Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial","has_exemption":false,"start_date":"2025-09-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07231497","publication_url":"https://clinicaltrials.gov/study/NCT07231497","title":"Cognitive Strategies in Early Psychosis 1","has_exemption":false,"start_date":"2025-10-31","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284589","publication_url":"https://clinicaltrials.gov/study/NCT07284589","title":"Evaluation of Ultralow Dose PET Imaging for Detecting SSTR2 Radiotracer Uptake","has_exemption":false,"start_date":"2025-12-11","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06666348","publication_url":"https://clinicaltrials.gov/study/NCT06666348","title":"A Phase 1/2 Study of Mirdametinib and Vinblastine for Newly Diagnosed or Previously Untreated Patients With Pediatric Low-grade Glioma and Activation of the MAPK Pathway","has_exemption":false,"start_date":"2026-01-12","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"St. Justine's Hospital","sponsor_slug":"st-justines-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07469384","publication_url":"https://clinicaltrials.gov/study/NCT07469384","title":"Sensory Contributions to Third Visual Pathway Dysfunction in Schizophrenia: Correlation and Causation","has_exemption":false,"start_date":"2026-02-01","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Nathan Kline Institute for Psychiatric Research","sponsor_slug":"nathan-kline-institute-for-psychiatric-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07126158","publication_url":"https://clinicaltrials.gov/study/NCT07126158","title":"Phase II Study of Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2026-04-10","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05763693","publication_url":"https://clinicaltrials.gov/study/NCT05763693","title":"Vitality in Infants Via Azithromycin for Neonates Trial","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07571161","publication_url":"https://clinicaltrials.gov/study/NCT07571161","title":"A Study of Donanemab Versus Placebo in Chinese Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07191717","publication_url":"https://clinicaltrials.gov/study/NCT07191717","title":"Phase II Minimal Residual Disease Study of Selective Estrogen Receptor Degrader Imlunestrant With Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Abemaciclib in Patients With ER+ Breast Cancer (MIRI)","has_exemption":false,"start_date":"2026-05-18","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07710885","publication_url":"https://clinicaltrials.gov/study/NCT07710885","title":"A Phase 3, Randomized-Controlled, Open-Label, Multi-Regional, International Study of Futibatinib (TAS-120) and Zimberelimab (AB122) in Combination With Gemcitabine Plus Cisplatin Versus Durvalumab or Pembrolizumab in Combination With Gemcitabine Plus Cisplatin for Patients With First-Line Advanced Biliary Tract Cancers","has_exemption":false,"start_date":"2026-06-24","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Taiho Pharmaceutical Co., Ltd.","sponsor_slug":"taiho-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07421518","publication_url":"https://clinicaltrials.gov/study/NCT07421518","title":"Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT2 Inhibitors","has_exemption":false,"start_date":"2026-06-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"AdventHealth Translational Research Institute","sponsor_slug":"adventhealth-translational-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07050862","publication_url":"https://clinicaltrials.gov/study/NCT07050862","title":"Circuity-guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Tobacco Use in Veterans: A Comparison of Insula-rTMS and Prefrontal-rTMS","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07263022","publication_url":"https://clinicaltrials.gov/study/NCT07263022","title":"Cognitive Strategies in Early Psychosis 2","has_exemption":false,"start_date":"2026-07-17","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06855433","publication_url":"https://clinicaltrials.gov/study/NCT06855433","title":"A Randomized, Double-Blind, Multi-Site Placebo Controlled Trial of Colchicine in Calcium Pyrophosphate Deposition Disease","has_exemption":false,"start_date":"2026-08-12","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07770698","publication_url":"https://clinicaltrials.gov/study/NCT07770698","title":"A Phase 1/2a, Open-Label, Dose Finding and Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Sonrotoclax (BGB-11417) in Combination With Other Agents in Pediatric Patients Aged 6 Months to 17 Years, With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2026-10-31","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07881120","publication_url":"https://clinicaltrials.gov/study/NCT07881120","title":"A 2-Stage Operationally Seamless Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Afimetoran in Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy","has_exemption":false,"start_date":"2026-10-31","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Beeline Medicines Corporation","sponsor_slug":"beeline-medicines-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07577804","publication_url":"https://clinicaltrials.gov/study/NCT07577804","title":"A Phase III, Randomised, Double-blind, Two-arm Study to Investigate the Efficacy and Safety of Treatment With CHF10196 Tablets (Florensocatib) Compared With Placebo for up to 78 Weeks, Followed by an Open-label Extension, in Male and Female Participants 12 to 85 Years of Age With Bronchiectasis","has_exemption":false,"start_date":"2026-11-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"Chiesi Farmaceutici S.p.A.","sponsor_slug":"chiesi-farmaceutici-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05684159","publication_url":"https://clinicaltrials.gov/study/NCT05684159","title":"A Phase II, Open-Label Study of NM8074 in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)","has_exemption":false,"start_date":"2027-11-30","completion_date":"2030-04-30","has_results":false,"results_due":false,"sponsor_name":"NovelMed Therapeutics","sponsor_slug":"novelmed-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03346694","publication_url":"https://clinicaltrials.gov/study/NCT03346694","title":"Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing","has_exemption":false,"start_date":"2018-05-01","completion_date":"2030-05-01","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07512336","publication_url":"https://clinicaltrials.gov/study/NCT07512336","title":"A Randomized Intra-Patient Controlled Trial of MagnetOs™ Putty vs Autograft in Instrumented Posterolateral Spinal Fusion in Idiopathic Scoliosis Patients","has_exemption":false,"start_date":"2026-05-01","completion_date":"2030-05-01","has_results":false,"results_due":false,"sponsor_name":"UMC Utrecht","sponsor_slug":"umc-utrecht","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07118839","publication_url":"https://clinicaltrials.gov/study/NCT07118839","title":"MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-05-18","completion_date":"2030-05-01","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07340554","publication_url":"https://clinicaltrials.gov/study/NCT07340554","title":"Neuroimaging of Instrumental Learning Networks in Adolescent Cannabis Use Treatment","has_exemption":false,"start_date":"2026-06-15","completion_date":"2030-05-01","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06585410","publication_url":"https://clinicaltrials.gov/study/NCT06585410","title":"A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC)","has_exemption":false,"start_date":"2025-01-02","completion_date":"2030-05-03","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284641","publication_url":"https://clinicaltrials.gov/study/NCT07284641","title":"Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)","has_exemption":false,"start_date":"2026-05-04","completion_date":"2030-05-04","has_results":false,"results_due":false,"sponsor_name":"Paul Szabolcs","sponsor_slug":"paul-szabolcs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06663722","publication_url":"https://clinicaltrials.gov/study/NCT06663722","title":"A Phase II b Study of Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease","has_exemption":false,"start_date":"2025-05-05","completion_date":"2030-05-05","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07863765","publication_url":"https://clinicaltrials.gov/study/NCT07863765","title":"Phase II Multi-Center Open-Label Trial of Enfortumab Vedotin Treatment for Patients With Aggressive Radioiodine Refractory Differentiated Thyroid Cancer, Aggressive Poorly Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Cancer and NUT Carcinoma","has_exemption":false,"start_date":"2027-05-05","completion_date":"2030-05-05","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07603557","publication_url":"https://clinicaltrials.gov/study/NCT07603557","title":"A Phase 2, Multicenter, Open-Label Study of Zolacabtagene Autoleucel (BMS-986353), CD19-Targeted NEX-T CAR T Cells, in Participants With Chronic Immune Thrombocytopenia (cITP) and Autoimmune Hemolytic Anemia (AIHA)","has_exemption":false,"start_date":"2026-08-31","completion_date":"2030-05-06","has_results":false,"results_due":false,"sponsor_name":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","sponsor_slug":"juno-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02653755","publication_url":"https://clinicaltrials.gov/study/NCT02653755","title":"The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer","has_exemption":false,"start_date":"2015-12-15","completion_date":"2030-05-15","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT07625215","publication_url":"https://clinicaltrials.gov/study/NCT07625215","title":"A Placebo-controlled, Parallel-group, Double Blind, Randomized, Multi-cohort Phase 2 Study to Investigate Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BAY 3670549 in Adult Participants With Atrial Fibrillation.","has_exemption":false,"start_date":"2026-09-01","completion_date":"2030-05-16","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06841354","publication_url":"https://clinicaltrials.gov/study/NCT06841354","title":"A Phase 3, Randomized, Open-label Study Comparing Efficacy and Safety of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as a Monotherapy and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With Previously Untreated Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Expressing PD-L1 at CPS Less Than 10 (TroFuse-011)","has_exemption":false,"start_date":"2025-03-16","completion_date":"2030-05-18","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07636811","publication_url":"https://clinicaltrials.gov/study/NCT07636811","title":"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study, to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Intrathecally Administered Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)","has_exemption":false,"start_date":"2026-08-17","completion_date":"2030-05-18","has_results":false,"results_due":false,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07684612","publication_url":"https://clinicaltrials.gov/study/NCT07684612","title":"A Randomized, Open-Label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan With Bevacizumab Compared With Platinum Doublet With Bevacizumab in Participants With Platinum-Sensitive Ovarian Cancer","has_exemption":false,"start_date":"2026-09-08","completion_date":"2030-05-21","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07447817","publication_url":"https://clinicaltrials.gov/study/NCT07447817","title":"Investigator-Initiated, Open-Label, Phase II Trial of Selinexor in Combination With Pacritinib in Patients With Myelofibrosis Who Are JAK Inhibitor-Naïve and Have Cytopenias (ILLUMINATE)","has_exemption":false,"start_date":"2026-05-04","completion_date":"2030-05-24","has_results":false,"results_due":false,"sponsor_name":"John Mascarenhas","sponsor_slug":"john-mascarenhas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06932757","publication_url":"https://clinicaltrials.gov/study/NCT06932757","title":"Phase 2 Trial of Adjuvant Quisinostat in High-Risk Uveal Melanoma","has_exemption":false,"start_date":"2025-05-27","completion_date":"2030-05-27","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05061550","publication_url":"https://clinicaltrials.gov/study/NCT05061550","title":"A Phase II, Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients With Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer (NeoCOAST-2)","has_exemption":false,"start_date":"2022-04-14","completion_date":"2030-05-28","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07052903","publication_url":"https://clinicaltrials.gov/study/NCT07052903","title":"TRITON-CM: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)","has_exemption":false,"start_date":"2025-07-02","completion_date":"2030-05-28","has_results":false,"results_due":false,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03701334","publication_url":"https://clinicaltrials.gov/study/NCT03701334","title":"A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)","has_exemption":false,"start_date":"2018-12-07","completion_date":"2030-05-29","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05775367","publication_url":"https://clinicaltrials.gov/study/NCT05775367","title":"Cochlear Implantation in Infants and Toddlers With Single-Sided Deafness","has_exemption":false,"start_date":"2023-07-07","completion_date":"2030-05-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06500884","publication_url":"https://clinicaltrials.gov/study/NCT06500884","title":"A Phase 2, Open-label, Randomized Study to Evaluate GPRC5D-related Oral Events","has_exemption":false,"start_date":"2024-08-26","completion_date":"2030-05-30","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07681674","publication_url":"https://clinicaltrials.gov/study/NCT07681674","title":"Bicycle Continued Access Protocol (BiCAP) for Participants Receiving a Bicycle Investigational Product on a BicycleTx Limited-Sponsored Study","has_exemption":false,"start_date":"2026-08-01","completion_date":"2030-05-30","has_results":false,"results_due":false,"sponsor_name":"BicycleTx Limited","sponsor_slug":"bicycletx-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07715799","publication_url":"https://clinicaltrials.gov/study/NCT07715799","title":"A Randomized Clinical Trial Using Noninvasive Brain Stimulation Combined With Written Exposure Therapy for PTSD in Military Personnel With TBI","has_exemption":false,"start_date":"2026-09-30","completion_date":"2030-05-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07565194","publication_url":"https://clinicaltrials.gov/study/NCT07565194","title":"Arousal-related Memory of Movie Clips During Individualized IPS Targeting fMRI and TBS.","has_exemption":false,"start_date":"2026-10-01","completion_date":"2030-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07565207","publication_url":"https://clinicaltrials.gov/study/NCT07565207","title":"The Effect of Within-network aiTBS on Cortical Excitability, Intrinsic Oscillatory Bands, and Behavioral Task Performance","has_exemption":false,"start_date":"2026-10-01","completion_date":"2030-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07696988","publication_url":"https://clinicaltrials.gov/study/NCT07696988","title":"Peripheral Neural Stimulation to Improve Microvascular Function and Limb Health in Veterans With Diabetic Peripheral Neuropathy","has_exemption":false,"start_date":"2026-11-02","completion_date":"2030-05-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02115295","publication_url":"https://clinicaltrials.gov/study/NCT02115295","title":"Phase II Study of Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With AML, HR MDS, or Myeloid Blast Phase of CML","has_exemption":false,"start_date":"2014-05-19","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02310399","publication_url":"https://clinicaltrials.gov/study/NCT02310399","title":"Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves","has_exemption":false,"start_date":"2014-05-31","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03394365","publication_url":"https://clinicaltrials.gov/study/NCT03394365","title":"Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy","has_exemption":false,"start_date":"2017-12-29","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Pierre Fabre Medicament","sponsor_slug":"pierre-fabre-medicament","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03618186","publication_url":"https://clinicaltrials.gov/study/NCT03618186","title":"Neuroimaging Study","has_exemption":false,"start_date":"2018-11-26","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03821857","publication_url":"https://clinicaltrials.gov/study/NCT03821857","title":"Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease","has_exemption":false,"start_date":"2019-06-27","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03972202","publication_url":"https://clinicaltrials.gov/study/NCT03972202","title":"The Role of Cerebellum in Speech","has_exemption":false,"start_date":"2019-09-15","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05254327","publication_url":"https://clinicaltrials.gov/study/NCT05254327","title":"A Randomized Phase 2 Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With and Without BMX-001 as Part of Total Neoadjuvant Therapy in Patients With Newly Diagnosed Locally Advanced Rectal Adenocarcinoma","has_exemption":false,"start_date":"2022-08-15","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05200559","publication_url":"https://clinicaltrials.gov/study/NCT05200559","title":"The Efficacy of T-regulatory Cell Depletion With E7777 Combined With Immune Checkpoint Inhibitor, Pembrolizumab, in Recurrent or Metastatic Solid Tumors: Phase I/II Study","has_exemption":false,"start_date":"2022-09-30","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Alexander B Olawaiye, MD","sponsor_slug":"alexander-b-olawaiye-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06205836","publication_url":"https://clinicaltrials.gov/study/NCT06205836","title":"Evaluating a Surgical-Sparing Approach Using Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer","has_exemption":false,"start_date":"2024-06-13","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06851338","publication_url":"https://clinicaltrials.gov/study/NCT06851338","title":"Pediatric Down Syndrome Post-Approval Study","has_exemption":false,"start_date":"2025-02-28","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Inspire Medical Systems, Inc.","sponsor_slug":"inspire-medical-systems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07010692","publication_url":"https://clinicaltrials.gov/study/NCT07010692","title":"Using Fractional Lasers and Tirbanibulin Ointment to Treat Keratinocyte Carcinomas","has_exemption":false,"start_date":"2025-05-16","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Bruce Robinson, MD","sponsor_slug":"bruce-robinson-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06876662","publication_url":"https://clinicaltrials.gov/study/NCT06876662","title":"Long-Term Safety of Pirtobrutinib in Participants From Study LOXO-BTK-18001 With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2025-05-20","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06876649","publication_url":"https://clinicaltrials.gov/study/NCT06876649","title":"A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib","has_exemption":false,"start_date":"2025-05-20","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06961955","publication_url":"https://clinicaltrials.gov/study/NCT06961955","title":"FAST NOVEMBER: A Phase II Randomized Trial of a 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer","has_exemption":false,"start_date":"2025-05-21","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07162181","publication_url":"https://clinicaltrials.gov/study/NCT07162181","title":"Long-Term Safety of Pirtobrutinib in Participants From Study J2N-MC-JZNJ With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2025-08-07","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06814496","publication_url":"https://clinicaltrials.gov/study/NCT06814496","title":"RAdiation comBined With BIspecific T-Cell Engager in DLL3 Expressing Tumors (RABBIT) Study: A Phase I/II Study of AMG757 / Tarlatamab and Concurrent Radiation Therapy in Tumors With High Prevalence of DLL3","has_exemption":false,"start_date":"2025-09-08","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07186842","publication_url":"https://clinicaltrials.gov/study/NCT07186842","title":"First-in-human, Open-label, Multi-site, Phase I/IIa, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of BNT329 in Participants With Advanced Solid Tumors Known to Express CA19-9","has_exemption":false,"start_date":"2025-11-18","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07097363","publication_url":"https://clinicaltrials.gov/study/NCT07097363","title":"A Pilot Study of Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for Upfront Treatment of Aggressive B-Cell Non-Hodgkin Lymphomas","has_exemption":false,"start_date":"2025-12-07","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224438","publication_url":"https://clinicaltrials.gov/study/NCT07224438","title":"Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea","has_exemption":false,"start_date":"2025-12-09","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Stephanie B. Seminara, MD","sponsor_slug":"stephanie-b-seminara-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07449702","publication_url":"https://clinicaltrials.gov/study/NCT07449702","title":"An Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of ORKA-001 in Participants With Moderate-to-Severe Plaque Psoriasis","has_exemption":false,"start_date":"2026-02-23","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Oruka Therapeutics, Inc.","sponsor_slug":"oruka-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218341","publication_url":"https://clinicaltrials.gov/study/NCT07218341","title":"Long-Term Safety of Pirtobrutinib in Participants From Study LOXO-BTK-20020 With BTKi Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","has_exemption":false,"start_date":"2026-03-09","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06410001","publication_url":"https://clinicaltrials.gov/study/NCT06410001","title":"CE-STAND: Cervical Epidural STimulation After Neurologic Damage","has_exemption":false,"start_date":"2026-03-15","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07526740","publication_url":"https://clinicaltrials.gov/study/NCT07526740","title":"Combining Brain Stimulation With Computerized Cognitive Training for MCI","has_exemption":false,"start_date":"2026-03-16","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07467707","publication_url":"https://clinicaltrials.gov/study/NCT07467707","title":"A Phase 3b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of an Adjuvanted Chikungunya Virus Virus-like Particle (CHIKV VLP) Vaccine for the Prevention of Chikungunya Disease in Adolescents (12 to <18 Years) and Adults (≥18 Years)","has_exemption":false,"start_date":"2026-05-26","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Bavarian Nordic","sponsor_slug":"bavarian-nordic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07682311","publication_url":"https://clinicaltrials.gov/study/NCT07682311","title":"Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator","has_exemption":false,"start_date":"2026-06-04","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07641426","publication_url":"https://clinicaltrials.gov/study/NCT07641426","title":"A 2 Part Dose-escalation Safety and Efficacy Study of CID-103 in Adults With Active and Chronic Active Renal Allograft Antibody Mediated Rejection.","has_exemption":false,"start_date":"2026-06-09","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"CASI Pharmaceuticals, Inc.","sponsor_slug":"casi-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07620574","publication_url":"https://clinicaltrials.gov/study/NCT07620574","title":"Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study","has_exemption":false,"start_date":"2026-07-30","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Exelixis","sponsor_slug":"exelixis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298421","publication_url":"https://clinicaltrials.gov/study/NCT07298421","title":"A Phase III Randomized Double-Blind Multi-Center Treat-Through Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Children Aged 2-17 Years With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2026-08-18","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07578467","publication_url":"https://clinicaltrials.gov/study/NCT07578467","title":"A Phase Ib/II Study Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs","has_exemption":false,"start_date":"2026-08-31","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06349083","publication_url":"https://clinicaltrials.gov/study/NCT06349083","title":"Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder","has_exemption":false,"start_date":"2026-09-01","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07699107","publication_url":"https://clinicaltrials.gov/study/NCT07699107","title":"Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial","has_exemption":false,"start_date":"2026-09-30","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Nisha Acharya","sponsor_slug":"nisha-acharya","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07576998","publication_url":"https://clinicaltrials.gov/study/NCT07576998","title":"PHIL™ (Precipitating Hydrophobic Injectable Liquid) Middle Meningeal Artery Embolization (MMAE) for First-Line Treatment of Chronic Subdural Hematoma (cSDH) IDE Trial (PHILFIRST)","has_exemption":false,"start_date":"2026-12-31","completion_date":"2030-05-31","has_results":false,"results_due":false,"sponsor_name":"Microvention-Terumo, Inc.","sponsor_slug":"microvention-terumo-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04900623","publication_url":"https://clinicaltrials.gov/study/NCT04900623","title":"Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study","has_exemption":false,"start_date":"2021-07-02","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Jonathan Schoenfeld, MD, MPH","sponsor_slug":"jonathan-schoenfeld-md-mph","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06872333","publication_url":"https://clinicaltrials.gov/study/NCT06872333","title":"Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathies and Other Red Cell Transfusion Dependent Disorders","has_exemption":false,"start_date":"2024-11-19","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06810778","publication_url":"https://clinicaltrials.gov/study/NCT06810778","title":"Phase I/II Study of Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)","has_exemption":false,"start_date":"2025-05-02","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07060066","publication_url":"https://clinicaltrials.gov/study/NCT07060066","title":"Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia","has_exemption":false,"start_date":"2025-10-23","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07032389","publication_url":"https://clinicaltrials.gov/study/NCT07032389","title":"Polypill Strategy for the Treatment of Patients After Acute Coronary Syndromes - A Multicenter Randomized Controlled Trial","has_exemption":false,"start_date":"2025-12-05","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07142551","publication_url":"https://clinicaltrials.gov/study/NCT07142551","title":"Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response Via Modulation of ANdrogen Receptor (the SPIDERMAN Trial)","has_exemption":false,"start_date":"2026-03-09","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07546942","publication_url":"https://clinicaltrials.gov/study/NCT07546942","title":"Autism Spectral Disorder (ASD) In Adolescent-Adults Treated by Multimodal Protocol: IV Autologous cSVF, Interval IV Autologous MSCs (Cryopreserved), Strick Ketogenic Diet RESET Program, and Fecal Microbiota Transplantation (FMT)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Black Tie Medical, Inc.","sponsor_slug":"black-tie-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566039","publication_url":"https://clinicaltrials.gov/study/NCT07566039","title":"Prospective Cohort Study of Athletes Following an Injection of Platelet-Poor Plasma Into an Acute Muscle Injury","has_exemption":false,"start_date":"2026-05-01","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07356284","publication_url":"https://clinicaltrials.gov/study/NCT07356284","title":"Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis","has_exemption":false,"start_date":"2026-05-19","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"ProMedica Health System","sponsor_slug":"promedica-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04457076","publication_url":"https://clinicaltrials.gov/study/NCT04457076","title":"A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate LevoCept™, a Long-Acting Reversible Intrauterine System for Contraceptive Efficacy, Safety, and Tolerability","has_exemption":false,"start_date":"2026-06-01","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Sebela Women's Health Inc.","sponsor_slug":"sebela-womens-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06996730","publication_url":"https://clinicaltrials.gov/study/NCT06996730","title":"A Double-Blind, Placebo-Controlled, Double-Dummy Study of Donanemab and RG6289 in PSEN1 E280A Mutation Carriers, and in Non-Randomized, Placebo-Treated Non-Carriers From the Same Kindred, to Evaluate the Efficacy and Safety of Donanemab, RG6289, or the Combination of Donanemab and RG6289, in the Treatment of Autosomal-Dominant Alzheimer's Disease","has_exemption":false,"start_date":"2026-07-08","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"Banner Health","sponsor_slug":"banner-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07420218","publication_url":"https://clinicaltrials.gov/study/NCT07420218","title":"Impact of FSH and Estradiol on Sympathetic Function in Menopausal Women","has_exemption":false,"start_date":"2026-09-01","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Delaware","sponsor_slug":"university-of-delaware","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07526545","publication_url":"https://clinicaltrials.gov/study/NCT07526545","title":"UPRISE (Urine Prostate Screening Integrated With MRI for Prostate Cancer Early Detection)","has_exemption":false,"start_date":"2026-12-01","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07859059","publication_url":"https://clinicaltrials.gov/study/NCT07859059","title":"A Phase I/II Study of Metronomic Temozolomide With Dexbrompheniramine for Patients With Recurrent High-Grade Glioma/Glioblastoma","has_exemption":false,"start_date":"2027-06-01","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06800092","publication_url":"https://clinicaltrials.gov/study/NCT06800092","title":"Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment","has_exemption":false,"start_date":"2027-06-15","completion_date":"2030-06-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07019454","publication_url":"https://clinicaltrials.gov/study/NCT07019454","title":"Baystate Health Physician Sponsored - Investigational Device Exception: Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms","has_exemption":false,"start_date":"2025-06-03","completion_date":"2030-06-03","has_results":false,"results_due":false,"sponsor_name":"Baystate Medical Center","sponsor_slug":"baystate-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215585","publication_url":"https://clinicaltrials.gov/study/NCT07215585","title":"A Phase III, Multicentre, Open-Label, Randomised Study Evaluating the Efficacy and Safety of R-mini-CHOP x2 Followed by AZD0486 Versus R-mini-CHOP x6 in Elderly or Unfit Participants With Newly Diagnosed Large B-cell Lymphoma (SOUNDTRACK-D2)","has_exemption":false,"start_date":"2025-11-11","completion_date":"2030-06-10","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07154290","publication_url":"https://clinicaltrials.gov/study/NCT07154290","title":"A Phase 2 Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Treatment-Experienced Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2026-03-18","completion_date":"2030-06-10","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05163288","publication_url":"https://clinicaltrials.gov/study/NCT05163288","title":"Effects of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C (NPC): A Phase III, Randomized, Placebo-controlled, Double-blind, Crossover Study","has_exemption":false,"start_date":"2022-06-30","completion_date":"2030-06-12","has_results":false,"results_due":false,"sponsor_name":"IntraBio Inc","sponsor_slug":"intrabio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226999","publication_url":"https://clinicaltrials.gov/study/NCT07226999","title":"A GLOBAL PHASE 2/3 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER","has_exemption":false,"start_date":"2025-12-09","completion_date":"2030-06-14","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04452591","publication_url":"https://clinicaltrials.gov/study/NCT04452591","title":"A Phase 3 Study of Cretostimogene Grenadenorepvec in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus-Calmette-Guerin (BCG)","has_exemption":false,"start_date":"2020-10-27","completion_date":"2030-06-16","has_results":false,"results_due":false,"sponsor_name":"CG Oncology, Inc.","sponsor_slug":"cg-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05170204","publication_url":"https://clinicaltrials.gov/study/NCT05170204","title":"A Phase I-III, Multicenter Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Patients Selected According to Biomarker Status, With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2022-11-01","completion_date":"2030-06-16","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07116616","publication_url":"https://clinicaltrials.gov/study/NCT07116616","title":"A Phase 1/2, Open-label, Multicenter Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2025-09-30","completion_date":"2030-06-17","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07851025","publication_url":"https://clinicaltrials.gov/study/NCT07851025","title":"A Randomised, Open-label, Phase III Study of Torvutatug Samrotecan in Combination With Bevacizumab Versus Bevacizumab Monotherapy as First-line Maintenance Treatment in Participants With Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (TREVI-OC-02)","has_exemption":false,"start_date":"2026-09-16","completion_date":"2030-06-18","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07639242","publication_url":"https://clinicaltrials.gov/study/NCT07639242","title":"Olomorasib Plus Pembrolizumab as First-Line Treatment for KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2030-06-21","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06077760","publication_url":"https://clinicaltrials.gov/study/NCT06077760","title":"A Phase 3, Randomized, Double-blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With Resected Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer (INTerpath-002)","has_exemption":false,"start_date":"2023-12-06","completion_date":"2030-06-25","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07603856","publication_url":"https://clinicaltrials.gov/study/NCT07603856","title":"A Randomized Phase II Study of Radiotherapy Plus Immune Checkpoint Inhibitor Therapy Versus Standard of Care Chemotherapy in Patients With Metastatic or Relapsed Non-Small Cell Lung Cancer Previously Treated With Immunotherapy","has_exemption":false,"start_date":"2026-12-12","completion_date":"2030-06-25","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06578247","publication_url":"https://clinicaltrials.gov/study/NCT06578247","title":"A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered in Combination With Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients With Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia","has_exemption":false,"start_date":"2024-11-19","completion_date":"2030-06-26","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07029828","publication_url":"https://clinicaltrials.gov/study/NCT07029828","title":"A LONG-TERM, DOUBLE-BLIND EXTENSION STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF RITLECITINIB IN PARTICIPANTS WITH SEVERE ALOPECIA AREATA WHO PREVIOUSLY COMPLETED STUDIES B7981027 OR B7981031","has_exemption":false,"start_date":"2025-09-10","completion_date":"2030-06-26","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04004169","publication_url":"https://clinicaltrials.gov/study/NCT04004169","title":"Closed-Loop Deep Brain Stimulation for Treatment-Resistant Depression","has_exemption":false,"start_date":"2019-07-18","completion_date":"2030-06-28","has_results":false,"results_due":false,"sponsor_name":"Andrew Krystal","sponsor_slug":"andrew-krystal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05161195","publication_url":"https://clinicaltrials.gov/study/NCT05161195","title":"A Post-trial Access Roll-over Study to Allow Access to Ribociclib (LEE011) for Patients Who Are on Ribociclib Treatment in Novartis-sponsored Study","has_exemption":false,"start_date":"2022-07-07","completion_date":"2030-06-28","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07127913","publication_url":"https://clinicaltrials.gov/study/NCT07127913","title":"Closed-Loop Deep Brain Stimulation for Bipolar Depression (PReSiDio-BP)","has_exemption":false,"start_date":"2025-07-16","completion_date":"2030-06-28","has_results":false,"results_due":false,"sponsor_name":"Andrew Krystal","sponsor_slug":"andrew-krystal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06994845","publication_url":"https://clinicaltrials.gov/study/NCT06994845","title":"A Single-arm, Multicenter, Phase III Study to Assess Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients of 2 to <18 Years of Age With Primary Immunoglobulin A Nephropathy (IgAN)","has_exemption":false,"start_date":"2025-11-27","completion_date":"2030-06-28","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06725550","publication_url":"https://clinicaltrials.gov/study/NCT06725550","title":"Integrative Medicine in Pain Management in Sickle Cell Disease: Assessing the Clinical Efficacy and Neurobiological Impact With Acupuncture, 2.0","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-06-28","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06966362","publication_url":"https://clinicaltrials.gov/study/NCT06966362","title":"Varenicline for Smoking Reduction in Veterans Unwilling to Quit","has_exemption":false,"start_date":"2026-08-17","completion_date":"2030-06-28","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03971669","publication_url":"https://clinicaltrials.gov/study/NCT03971669","title":"Collection of Blood Samples for In-Vitro Studies From Healthy Adult Blood Donors Who Have Received Oral Typhoid Vaccine (TY21A)","has_exemption":false,"start_date":"2004-01-16","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01630850","publication_url":"https://clinicaltrials.gov/study/NCT01630850","title":"Islet Transplantation in Patients With \"Brittle\" Type I Diabetes","has_exemption":false,"start_date":"2012-05-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03434392","publication_url":"https://clinicaltrials.gov/study/NCT03434392","title":"QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing","has_exemption":false,"start_date":"2017-10-24","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Anna Evans Phillips","sponsor_slug":"anna-evans-phillips","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04305145","publication_url":"https://clinicaltrials.gov/study/NCT04305145","title":"Phase II Study of Infliximab for the Treatment of Immune Checkpoint Inhibitor Colitis","has_exemption":false,"start_date":"2020-08-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04753970","publication_url":"https://clinicaltrials.gov/study/NCT04753970","title":"Retinal Vasoreactivity is a Marker for Cerebral Small Vessel Disease Progression","has_exemption":false,"start_date":"2021-02-09","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05422222","publication_url":"https://clinicaltrials.gov/study/NCT05422222","title":"A Phase 3 Study Evaluating the Pharmacokinetics, Safety, and Tolerability of VX-121/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Through 11 Years of Age","has_exemption":false,"start_date":"2022-06-21","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05551858","publication_url":"https://clinicaltrials.gov/study/NCT05551858","title":"A Phase 1/2 Trial to Test the Safety of a CCK Receptor Antagonist, Proglumide, in Management of Chronic Pancreatitis Symptoms and Pain for 12 to 24 Months","has_exemption":false,"start_date":"2022-11-17","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05633615","publication_url":"https://clinicaltrials.gov/study/NCT05633615","title":"A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-Cell Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Grade IIIB Follicular Lymphoma","has_exemption":false,"start_date":"2023-06-12","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06118892","publication_url":"https://clinicaltrials.gov/study/NCT06118892","title":"Post-Market Evaluation of the MISHA® Knee System for Symptom Relief in Subjects With Medial Knee Osteoarthritis","has_exemption":false,"start_date":"2023-11-03","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Moximed","sponsor_slug":"moximed","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06384573","publication_url":"https://clinicaltrials.gov/study/NCT06384573","title":"The Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Amyloid Removal Trial (ART): A Phase IIIb/IV Open-Label Study of Lecanemab to Evaluate Prevention and Progression of Dominantly Inherited Alzheimer's Disease","has_exemption":false,"start_date":"2024-06-10","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07580183","publication_url":"https://clinicaltrials.gov/study/NCT07580183","title":"Investigations of Spatial Recognition Memory to Improve Cognitive Outcomes in Epilepsy Surgery","has_exemption":false,"start_date":"2024-07-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06241430","publication_url":"https://clinicaltrials.gov/study/NCT06241430","title":"Hemodynamic-Guided Optimization With the CardioMEMS Device of Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Mitral Transcatheter Edge-to-Edge Repair With the MitraClip Device","has_exemption":false,"start_date":"2024-12-18","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06767683","publication_url":"https://clinicaltrials.gov/study/NCT06767683","title":"An Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Durability of Treatment Effect of ALKS 2680 in Subjects With Narcolepsy Type 1 and Type 2 and Idiopathic Hypersomnia","has_exemption":false,"start_date":"2025-01-27","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Alkermes, Inc.","sponsor_slug":"alkermes-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06904313","publication_url":"https://clinicaltrials.gov/study/NCT06904313","title":"Evaluation of Ultralow Dose PET Imaging for Detecting PSMA Expression","has_exemption":false,"start_date":"2025-05-12","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06956391","publication_url":"https://clinicaltrials.gov/study/NCT06956391","title":"Evaluation of Ultralow Dose PET Imaging for Detecting 18F-FDG Uptake","has_exemption":false,"start_date":"2025-05-12","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07542158","publication_url":"https://clinicaltrials.gov/study/NCT07542158","title":"Evaluation of Ultralow Dose PET Imaging for Detecting 18F-FDOPA Uptake","has_exemption":false,"start_date":"2025-05-12","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07012993","publication_url":"https://clinicaltrials.gov/study/NCT07012993","title":"Evaluation of Ultralow Dose PET Imaging for Detecting Amyloid Tracer Uptake","has_exemption":false,"start_date":"2025-05-20","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07038343","publication_url":"https://clinicaltrials.gov/study/NCT07038343","title":"A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2025-06-04","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Avenzo Therapeutics, Inc.","sponsor_slug":"avenzo-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06464926","publication_url":"https://clinicaltrials.gov/study/NCT06464926","title":"A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System","has_exemption":false,"start_date":"2025-06-23","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Enterra Medical, Inc.","sponsor_slug":"enterra-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06953089","publication_url":"https://clinicaltrials.gov/study/NCT06953089","title":"A Phase II, Multicenter, Open-Label Trial of DB-1311 in Combination With BNT327 or DB-1305 in Participants With Advanced/Metastatic Solid Tumors","has_exemption":false,"start_date":"2025-07-18","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"DualityBio Inc.","sponsor_slug":"dualitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284563","publication_url":"https://clinicaltrials.gov/study/NCT07284563","title":"Evaluation of Ultralow Dose PET Imaging for Detecting 18F-NaF Uptake","has_exemption":false,"start_date":"2025-09-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06726161","publication_url":"https://clinicaltrials.gov/study/NCT06726161","title":"Phase 1/2 Randomized, Controlled, Open-label Trial of Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ Unresectable Hepatocellular Carcinoma (HCC)","has_exemption":false,"start_date":"2025-09-05","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"RayzeBio, Inc.","sponsor_slug":"rayzebio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07212686","publication_url":"https://clinicaltrials.gov/study/NCT07212686","title":"An Open-Label, Single-Center Study of Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension Despite Receiving Fluid Therapy and Vasoactive Therapy","has_exemption":false,"start_date":"2025-09-09","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Todd Sweberg","sponsor_slug":"todd-sweberg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06520098","publication_url":"https://clinicaltrials.gov/study/NCT06520098","title":"Benefit of Venetoclax Addition (\"Benefit VA\") in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)","has_exemption":false,"start_date":"2025-10-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284576","publication_url":"https://clinicaltrials.gov/study/NCT07284576","title":"Evaluation of 0.25mCi PET Imaging for Detecting Cardiac Perfusion","has_exemption":false,"start_date":"2025-12-16","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Akiva Mintz","sponsor_slug":"akiva-mintz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06949423","publication_url":"https://clinicaltrials.gov/study/NCT06949423","title":"Accessing the Impact of Deep TMS Neuromodulation on Neural Circuits Associated With Alcohol Use Disorder","has_exemption":false,"start_date":"2025-12-17","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07668869","publication_url":"https://clinicaltrials.gov/study/NCT07668869","title":"Tumor Treating Fields (TTFields) Concomitant With Stereotactic Radiosurgery Based on FET-PET vs TTFields Alone for the Treatment of Recurrent, Glioblastoma (Tarrget 2.0)","has_exemption":false,"start_date":"2025-12-30","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Prof. Franciszek Lukaszczyk Memorial Oncology Center","sponsor_slug":"prof-franciszek-lukaszczyk-memorial-oncology-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214649","publication_url":"https://clinicaltrials.gov/study/NCT07214649","title":"A Prospective Study Using Patient-Derived Extrahepatic Cholangiocyte Organoids for Refractory Bile Leaks","has_exemption":false,"start_date":"2026-01-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","sponsor_slug":"fondazione-policlinico-universitario-agostino-gemelli-irccs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07084441","publication_url":"https://clinicaltrials.gov/study/NCT07084441","title":"Comparison of Outcomes of Management of Bowel Obstruction","has_exemption":false,"start_date":"2026-02-03","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223814","publication_url":"https://clinicaltrials.gov/study/NCT07223814","title":"Bleximenib or Placebo in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for the Treatment of Patients With Newly Diagnosed KMT2A-rearranged or NPM1-mutant Acute Myeloid Leukemia Eligible for Intensive Chemotherapy: a Double-blind Phase 3 Study","has_exemption":false,"start_date":"2026-03-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Stichting Hemato-Oncologie voor Volwassenen Nederland","sponsor_slug":"stichting-hemato-oncologie-voor-volwassenen-nederland","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06474273","publication_url":"https://clinicaltrials.gov/study/NCT06474273","title":"A Multicenter Randomized Controlled Trial to Treat Acute t Cell Mediated Rejection in Kidney and Kidney-pancreas Transplant Recipients","has_exemption":false,"start_date":"2026-03-13","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Sydney","sponsor_slug":"university-of-sydney","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07067463","publication_url":"https://clinicaltrials.gov/study/NCT07067463","title":"A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Primary Progressive Multiple Sclerosis","has_exemption":false,"start_date":"2026-03-23","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Zenas BioPharma (USA), LLC","sponsor_slug":"zenas-biopharma-usa-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07299019","publication_url":"https://clinicaltrials.gov/study/NCT07299019","title":"A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Non-active Secondary Progressive Multiple Sclerosis","has_exemption":false,"start_date":"2026-03-23","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Zenas BioPharma (USA), LLC","sponsor_slug":"zenas-biopharma-usa-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07415044","publication_url":"https://clinicaltrials.gov/study/NCT07415044","title":"A Randomized, Multicenter, Double-Blind, Placebo-Controlled Development Program to Evaluate the Efficacy and Safety of LY4268989 (MORF-057) for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis (EMERALD-3)","has_exemption":false,"start_date":"2026-03-26","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07428499","publication_url":"https://clinicaltrials.gov/study/NCT07428499","title":"A Phase 3 Extension Study of siRNA Targeting of Prekallikrein With ADX-324 in Participants With Hereditary Angioedema","has_exemption":false,"start_date":"2026-04-02","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"ADARx Pharmaceuticals, Inc.","sponsor_slug":"adarx-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07135596","publication_url":"https://clinicaltrials.gov/study/NCT07135596","title":"Research on the Effectiveness and Safety of Treatment With OviTex® PRS - a Breast Reconstruction Evaluation","has_exemption":false,"start_date":"2026-04-10","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Tela Bio Inc","sponsor_slug":"tela-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566052","publication_url":"https://clinicaltrials.gov/study/NCT07566052","title":"A Randomized, Open-label, Phase 3 Study of Setidegrasib (ASP3082) Versus Docetaxel in Participants With KRAS G12D-mutated Locally Advanced (Unresectable) or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on or After Platinum Based Chemotherapy and Checkpoint Inhibitor Therapy (CPI)","has_exemption":false,"start_date":"2026-04-28","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07475286","publication_url":"https://clinicaltrials.gov/study/NCT07475286","title":"A Phase II Single Arm Study of Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis","has_exemption":false,"start_date":"2026-06-12","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Mohammad Haroon Asif Choudry","sponsor_slug":"mohammad-haroon-asif-choudry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07436793","publication_url":"https://clinicaltrials.gov/study/NCT07436793","title":"Evaluating Promising Progestins in Endometrial Cancer Through a Rotating Umbrella Surgical Window Trial - The PRO-WINDOW TRIAL for Endometrial Cancer","has_exemption":false,"start_date":"2026-06-15","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"New Mexico Cancer Research Alliance","sponsor_slug":"new-mexico-cancer-research-alliance","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07635940","publication_url":"https://clinicaltrials.gov/study/NCT07635940","title":"Effects of Transcranial Magnetic Stimulation on Social Cognition, Cognitive Processing, and Functional Brain Architecture in Psychopathy","has_exemption":false,"start_date":"2026-07-13","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07398508","publication_url":"https://clinicaltrials.gov/study/NCT07398508","title":"Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease: Double-blind Placebo-controlled Randomized Crossover Clinical Trial","has_exemption":false,"start_date":"2026-08-10","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Stephen G. Kaler","sponsor_slug":"stephen-g-kaler","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07265830","publication_url":"https://clinicaltrials.gov/study/NCT07265830","title":"The Building Adaptive School-based Interventions for Caries Study (BASICS): A Phase III Sequential, Multiple-Assignment, Randomized Trial of Minimally Invasive Therapies to Reduce Treatment Nonresponse","has_exemption":false,"start_date":"2026-08-18","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07680829","publication_url":"https://clinicaltrials.gov/study/NCT07680829","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of DR10624 Added to Standard Icosapent Ethyl Therapy in Adults With Severe Hypertriglyceridemia","has_exemption":false,"start_date":"2026-08-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Zhejiang Doer Biologics Co., Ltd.","sponsor_slug":"zhejiang-doer-biologics-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07745569","publication_url":"https://clinicaltrials.gov/study/NCT07745569","title":"Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies","has_exemption":false,"start_date":"2026-08-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of New Mexico","sponsor_slug":"university-of-new-mexico","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07673250","publication_url":"https://clinicaltrials.gov/study/NCT07673250","title":"Personalized Ventilator Settings for Patients on ECMO (PEEPECMO)","has_exemption":false,"start_date":"2026-09-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07210606","publication_url":"https://clinicaltrials.gov/study/NCT07210606","title":"Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment","has_exemption":false,"start_date":"2026-09-16","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07849530","publication_url":"https://clinicaltrials.gov/study/NCT07849530","title":"Developing Transcranial Magnetic Stimulation as a Therapeutic Modality for Methamphetamine Use Disorder During Pregnancy","has_exemption":false,"start_date":"2026-09-30","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07873450","publication_url":"https://clinicaltrials.gov/study/NCT07873450","title":"A First-in-Human Phase 1/2 Dose Escalation and Treatment Optimization Study Evaluating Safety, Tolerability, and Preliminary Efficacy of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET","has_exemption":false,"start_date":"2026-10-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Full-Life Technologies UK Limited","sponsor_slug":"full-life-technologies-uk-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07839013","publication_url":"https://clinicaltrials.gov/study/NCT07839013","title":"Brain Function and Cognitive Control Training in Children With Obsessive-Compulsive Symptoms","has_exemption":false,"start_date":"2026-10-15","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07632898","publication_url":"https://clinicaltrials.gov/study/NCT07632898","title":"Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability of IKT-001 in Pulmonary Arterial Hypertension","has_exemption":false,"start_date":"2026-10-23","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Inhibikase Therapeutics","sponsor_slug":"inhibikase-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07763873","publication_url":"https://clinicaltrials.gov/study/NCT07763873","title":"A Pre-Market, Multicentre, Prospective, Open-Label, Within-Subject, Non-Randomised, Interventional Study Examining Acceptability of Auditory Implant Fitting Software Technologies","has_exemption":false,"start_date":"2026-10-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Cochlear","sponsor_slug":"cochlear","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07850076","publication_url":"https://clinicaltrials.gov/study/NCT07850076","title":"Official Title: A Phase 1/2 Multicenter, Open-label, First-in-Human Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of CTX460, a Lipid Nanoparticle Formulation of SyNTase Editing Components for In Vivo Editing of the Serine Protease Inhibitor A1 (SERPINA1) Gene in Adults With Emphysema Associated With Severe Alpha-1 Antitrypsin Deficiency (AATD)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"CRISPR Therapeutics","sponsor_slug":"crispr-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07573436","publication_url":"https://clinicaltrials.gov/study/NCT07573436","title":"A Phase 1/2 Study of Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)","has_exemption":false,"start_date":"2026-11-30","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07766317","publication_url":"https://clinicaltrials.gov/study/NCT07766317","title":"A Phase I/II Open-Label Clinical Study of Autologous Tumor Infiltrating Lymphocyte Infusion (GT201) in the Treatment of Advanced Solid Tumors","has_exemption":false,"start_date":"2026-11-30","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Gritbio Medicine, Inc.","sponsor_slug":"gritbio-medicine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07836023","publication_url":"https://clinicaltrials.gov/study/NCT07836023","title":"Unbinding Forever Chemicals: an Intervention Trial for Reducing PFAS Body Burden and Assessing the Role of the Microbiome","has_exemption":false,"start_date":"2026-11-30","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07726862","publication_url":"https://clinicaltrials.gov/study/NCT07726862","title":"Characterizing Local Mucosal Responses to Live Attenuated Influenza Vaccine in Healthy Adults","has_exemption":false,"start_date":"2026-12-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04172779","publication_url":"https://clinicaltrials.gov/study/NCT04172779","title":"Phase II Clinical Trial of Low-dose Erlotinib for Hepatocellular Carcinoma Chemoprevention","has_exemption":false,"start_date":"2026-12-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07796100","publication_url":"https://clinicaltrials.gov/study/NCT07796100","title":"A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody-drug Conjugate (ADC) in Combination With a Checkpoint Inhibitor Compared to Standard of Care Platinum Based Chemotherapy With a Checkpoint Inhibitor as First-line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer","has_exemption":false,"start_date":"2026-12-31","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Zai Lab (Shanghai) Co., Ltd.","sponsor_slug":"zai-lab-shanghai-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288463","publication_url":"https://clinicaltrials.gov/study/NCT07288463","title":"Hearing Loss and Brain Health Study","has_exemption":false,"start_date":"2027-07-01","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05976802","publication_url":"https://clinicaltrials.gov/study/NCT05976802","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam BID for 2 Weeks, Followed by QD for 4 Weeks, in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis","has_exemption":false,"start_date":"2029-06-30","completion_date":"2030-06-30","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04814082","publication_url":"https://clinicaltrials.gov/study/NCT04814082","title":"Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot","has_exemption":false,"start_date":"2021-02-01","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"LifeBridge Health","sponsor_slug":"lifebridge-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05564377","publication_url":"https://clinicaltrials.gov/study/NCT05564377","title":"Molecular Analysis for Combination Therapy Choice (ComboMATCH)","has_exemption":false,"start_date":"2023-04-07","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06692738","publication_url":"https://clinicaltrials.gov/study/NCT06692738","title":"A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer Whose Tumors Express PD-L1 (ARTEMIDE-Lung02)","has_exemption":false,"start_date":"2024-11-18","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07121595","publication_url":"https://clinicaltrials.gov/study/NCT07121595","title":"PRECEDENT: Pilot Phase II Study of Personalized Radiation to the Contralateral Neck Directed by Sentinel Node Evaluation in Lateralized Oral Cavity Squamous Cell Carcinoma","has_exemption":false,"start_date":"2025-07-17","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07519772","publication_url":"https://clinicaltrials.gov/study/NCT07519772","title":"A Phase 1b/2 Study to Evaluate the Safety and Efficacy of MK-1045 Monotherapy or in Combination With Other Anticancer Agents in Participants With Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2026-05-03","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07675174","publication_url":"https://clinicaltrials.gov/study/NCT07675174","title":"A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Abatacept for the Prevention of Graft-versus-Host Disease (GvHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07624305","publication_url":"https://clinicaltrials.gov/study/NCT07624305","title":"A Phase III, Randomised, Double-blind, Study to Evaluate the Effect of Balcinrenone/Dapagliflozin Compared With Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Chronic Kidney Disease (Stage 3b and 4)","has_exemption":false,"start_date":"2026-09-01","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07464028","publication_url":"https://clinicaltrials.gov/study/NCT07464028","title":"Assessing Target Engagement for Terazosin in Parkinson's Disease (TZPD2)","has_exemption":false,"start_date":"2028-07-01","completion_date":"2030-07-01","has_results":false,"results_due":false,"sponsor_name":"Ergun Y. Uc","sponsor_slug":"ergun-y-uc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07683754","publication_url":"https://clinicaltrials.gov/study/NCT07683754","title":"A Global, Interventional, Open-label Trial of T-DXd-based Therapy Followed by Palbociclib, Endocrine Therapy and Dual HER2 Blockade in First-line HER2+/ HR+ Advanced or Metastatic Breast Cancer and Retreatment With T-DXd (DB-Guide)","has_exemption":false,"start_date":"2026-09-18","completion_date":"2030-07-04","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05459935","publication_url":"https://clinicaltrials.gov/study/NCT05459935","title":"Treatment of Pediatric Hypertrophic Tonsils and Pediatric Obstructive Sleep Apnea by Non-invasive Photobiomodulation","has_exemption":false,"start_date":"2022-10-15","completion_date":"2030-07-06","has_results":false,"results_due":false,"sponsor_name":"University of Alberta","sponsor_slug":"university-of-alberta","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04715646","publication_url":"https://clinicaltrials.gov/study/NCT04715646","title":"Open-Label, Single-Arm, Multicenter Study to Evaluate Long-Term Safety and Tolerability of Brivaracetam Used as Adjunctive Treatment in Pediatric Study Participants With Epilepsy","has_exemption":false,"start_date":"2021-03-11","completion_date":"2030-07-08","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07559513","publication_url":"https://clinicaltrials.gov/study/NCT07559513","title":"Phase 3 Evaluation of the Safety, Pharmacokinetics, and Efficacy of Garetosmab (Anti-Activin A Monoclonal Antibody) in Children and Adolescents With Fibrodysplasia Ossificans Progressiva","has_exemption":false,"start_date":"2027-02-02","completion_date":"2030-07-08","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04684602","publication_url":"https://clinicaltrials.gov/study/NCT04684602","title":"Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions","has_exemption":false,"start_date":"2020-07-09","completion_date":"2030-07-09","has_results":false,"results_due":false,"sponsor_name":"Thomas Advanced Medical LLC","sponsor_slug":"thomas-advanced-medical-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07789483","publication_url":"https://clinicaltrials.gov/study/NCT07789483","title":"An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of ALXN2220 in Adult Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)","has_exemption":false,"start_date":"2027-11-23","completion_date":"2030-07-11","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07146906","publication_url":"https://clinicaltrials.gov/study/NCT07146906","title":"An Open-label, Multicenter Study to Assess the Effect of Zigakibart Treatment on Histologic, Circulating, and Excreted Markers of Kidney Disease and Dysfunction in Adult Patients With IgA Nephropathy.","has_exemption":false,"start_date":"2026-03-26","completion_date":"2030-07-12","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06054230","publication_url":"https://clinicaltrials.gov/study/NCT06054230","title":"Genomic Sequencing for Evaluation of Fetal Structural Anomalies","has_exemption":false,"start_date":"2023-09-18","completion_date":"2030-07-15","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06678737","publication_url":"https://clinicaltrials.gov/study/NCT06678737","title":"CBIT+TMS R33 Phase","has_exemption":false,"start_date":"2025-02-27","completion_date":"2030-07-15","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07002216","publication_url":"https://clinicaltrials.gov/study/NCT07002216","title":"A Phase 2 Trial of Abbreviated Brentuximab Vedotin, Etoposide, Cyclophosphamide, Adriamycin, Dacarbazine, and Dexamethasone (BrECADD) Therapy in Stage 2 B-IV Hodgkin Lymphoma","has_exemption":false,"start_date":"2025-07-15","completion_date":"2030-07-15","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220720","publication_url":"https://clinicaltrials.gov/study/NCT07220720","title":"Inclusion of POSLUMA® ((18)F-rhPSMA-7.3) PET-CT Imaging Improves Diagnostic Accuracy of Clinically-Significant Prostate Cancer Diagnosis in Men With PIRADS 2 and 3 Lesions on MRI","has_exemption":false,"start_date":"2025-11-04","completion_date":"2030-07-15","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07751042","publication_url":"https://clinicaltrials.gov/study/NCT07751042","title":"A Phase 1/2, Open-label, Multi-center, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Antitumor Activity of STX-003 Delivered Intravenously in Patients With Advanced Solid Tumors as a Monotherapy or in Combination With Pembrolizumab","has_exemption":false,"start_date":"2026-06-30","completion_date":"2030-07-17","has_results":false,"results_due":false,"sponsor_name":"Strand Therapeutics Inc.","sponsor_slug":"strand-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02543983","publication_url":"https://clinicaltrials.gov/study/NCT02543983","title":"The Neurobiology of Suicide","has_exemption":false,"start_date":"2015-12-01","completion_date":"2030-07-21","has_results":false,"results_due":false,"sponsor_name":"National Institute of Mental Health (NIMH)","sponsor_slug":"national-institute-of-mental-health-nimh","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05442216","publication_url":"https://clinicaltrials.gov/study/NCT05442216","title":"Phase II Study of TAGraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Previous Exposure to HypOmethylatiNG Agents","has_exemption":false,"start_date":"2024-05-01","completion_date":"2030-07-21","has_results":false,"results_due":false,"sponsor_name":"Joshua Zeidner","sponsor_slug":"joshua-zeidner","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07286266","publication_url":"https://clinicaltrials.gov/study/NCT07286266","title":"A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer","has_exemption":false,"start_date":"2026-06-18","completion_date":"2030-07-22","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07843472","publication_url":"https://clinicaltrials.gov/study/NCT07843472","title":"A Phase III, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Once Weekly Petrelintide Vs. Placebo in Participants With Overweight Or Obesity And Established Cardiovascular Disease","has_exemption":false,"start_date":"2026-09-30","completion_date":"2030-07-28","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05895786","publication_url":"https://clinicaltrials.gov/study/NCT05895786","title":"A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES (INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS)","has_exemption":false,"start_date":"2023-05-20","completion_date":"2030-07-29","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06022939","publication_url":"https://clinicaltrials.gov/study/NCT06022939","title":"A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients With Newly Diagnosed AL Amyloidosis","has_exemption":false,"start_date":"2024-07-01","completion_date":"2030-07-29","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07404826","publication_url":"https://clinicaltrials.gov/study/NCT07404826","title":"A Randomized, Sham Controlled Clinical Trial to Assess the Effectiveness of a Positive End Expiratory Device for Accelerating and Maintaining Pulmonary Rehabilitation Gains","has_exemption":false,"start_date":"2026-07-16","completion_date":"2030-07-29","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06969755","publication_url":"https://clinicaltrials.gov/study/NCT06969755","title":"Biomarkers to Enhance Early Schizophrenia Treatment","has_exemption":false,"start_date":"2024-09-04","completion_date":"2030-07-30","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06561386","publication_url":"https://clinicaltrials.gov/study/NCT06561386","title":"A Phase 3, Randomized, Open-label Study of Nivolumab + Relatlimab Fixed-dose Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy as First-line Treatment for Participants With Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer and With Tumor Cell PD-L1 Expression ≥ 1%","has_exemption":false,"start_date":"2024-10-07","completion_date":"2030-07-30","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06731413","publication_url":"https://clinicaltrials.gov/study/NCT06731413","title":"Phase 2 Study to Evaluate Reduced Dose Chemotherapy in Combination With Anti-PD-1 Therapy as First Line Treatment in Vulnerable or Older Adults (Vulnerable or Age ≥70) With Advanced PD-L1 TPS <50% Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2025-02-11","completion_date":"2030-07-30","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07040566","publication_url":"https://clinicaltrials.gov/study/NCT07040566","title":"Investigating Efficacious E-Cigarette Interventions and Cessation Effects on Cancer-Related Biomarkers: A Randomized Trial of Varenicline in Adults","has_exemption":false,"start_date":"2025-10-14","completion_date":"2030-07-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04373785","publication_url":"https://clinicaltrials.gov/study/NCT04373785","title":"A Multi-Center Pilot/Phase I and Phase II Clinical Trial of NG101m Adjuvant Therapy in Newly Diagnosed Glioblastoma Patients","has_exemption":false,"start_date":"2027-01-01","completion_date":"2030-07-30","has_results":false,"results_due":false,"sponsor_name":"NeuGATE Theranostics","sponsor_slug":"neugate-theranostics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06716866","publication_url":"https://clinicaltrials.gov/study/NCT06716866","title":"Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy - Effect of Temporal Interference on Biomarkers of Epilepsy","has_exemption":false,"start_date":"2019-01-16","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04188535","publication_url":"https://clinicaltrials.gov/study/NCT04188535","title":"RELAY: Repeated Magnetic Resonance Imaging Examinations to Analyze and Assess Your Cancer: A Prospective Study on the Use of Serial Magnetic Resonance Imaging in the Assessment of Changes During Treatment With Radiation Therapy","has_exemption":false,"start_date":"2020-01-15","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04318717","publication_url":"https://clinicaltrials.gov/study/NCT04318717","title":"Adjuvant Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma","has_exemption":true,"start_date":"2020-05-29","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04743141","publication_url":"https://clinicaltrials.gov/study/NCT04743141","title":"Phase 3, Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age","has_exemption":false,"start_date":"2021-04-28","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05145127","publication_url":"https://clinicaltrials.gov/study/NCT05145127","title":"AN OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF MARSTACIMAB PROPHYLAXIS IN SEVERE (COAGULATION FACTOR ACTIVITY <1%) HEMOPHILIA A PARTICIPANTS WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY ≤2%) WITH OR WITHOUT INHIBITORS","has_exemption":false,"start_date":"2021-11-17","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05469893","publication_url":"https://clinicaltrials.gov/study/NCT05469893","title":"Immuno-PRISM (PRecision Intervention Smoldering Myeloma): A Randomized Phase II Platform Study of Select Immunotherapies for High-Risk Smoldering Myeloma","has_exemption":false,"start_date":"2022-08-10","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Irene Ghobrial, MD","sponsor_slug":"irene-ghobrial-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05131919","publication_url":"https://clinicaltrials.gov/study/NCT05131919","title":"Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers. The PUMA Study","has_exemption":false,"start_date":"2022-12-22","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"The Netherlands Cancer Institute","sponsor_slug":"the-netherlands-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05768139","publication_url":"https://clinicaltrials.gov/study/NCT05768139","title":"First-in-Human Study of STX-478, a Mutant-Selective PI3Kα Inhibitor as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-04-17","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06072131","publication_url":"https://clinicaltrials.gov/study/NCT06072131","title":"A Phase 3, Randomized, Open-Label Study Comparing the Efficacy and Safety of the Combination of Beleodaq-CHOP or Folotyn-COP to the CHOP Regimen Alone in Newly Diagnosed Patients With Peripheral T-Cell Lymphoma","has_exemption":false,"start_date":"2023-10-04","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Acrotech Biopharma Inc.","sponsor_slug":"acrotech-biopharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05821855","publication_url":"https://clinicaltrials.gov/study/NCT05821855","title":"A Postmarketing Study Evaluating the Effectiveness and Safety of the XEN45 Glaucoma Treatment System in Subjects With Open-Angle Glaucoma in China","has_exemption":false,"start_date":"2024-01-09","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05828823","publication_url":"https://clinicaltrials.gov/study/NCT05828823","title":"Comparative Effectiveness of an Individualized Model of Hemodialysis Versus Conventional Hemodialysis","has_exemption":false,"start_date":"2024-02-26","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06532656","publication_url":"https://clinicaltrials.gov/study/NCT06532656","title":"A Phase 2/3, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1","has_exemption":false,"start_date":"2024-11-20","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07007273","publication_url":"https://clinicaltrials.gov/study/NCT07007273","title":"Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma","has_exemption":false,"start_date":"2025-06-20","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06992440","publication_url":"https://clinicaltrials.gov/study/NCT06992440","title":"Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension","has_exemption":false,"start_date":"2025-06-26","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Gustavo A Heresi, MD, MS","sponsor_slug":"gustavo-a-heresi-md-ms","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06950385","publication_url":"https://clinicaltrials.gov/study/NCT06950385","title":"A Phase 3, Multi-Site, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of eRapa to Improve Clinical Outcomes in Patients With Familial Adenomatous Polyposis","has_exemption":false,"start_date":"2025-07-18","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Rapamycin Holdings Inc.","sponsor_slug":"rapamycin-holdings-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06596447","publication_url":"https://clinicaltrials.gov/study/NCT06596447","title":"Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation","has_exemption":false,"start_date":"2025-08-01","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06912763","publication_url":"https://clinicaltrials.gov/study/NCT06912763","title":"Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)","has_exemption":false,"start_date":"2025-08-08","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07276035","publication_url":"https://clinicaltrials.gov/study/NCT07276035","title":"TMS Neuromodulation of Brain-to-Stomach Circuits in Chronic Nausea","has_exemption":false,"start_date":"2026-01-28","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"David Levinthal","sponsor_slug":"david-levinthal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227584","publication_url":"https://clinicaltrials.gov/study/NCT07227584","title":"Treatment of Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in Adolescents and Young Adults (AYAs)","has_exemption":false,"start_date":"2026-04-03","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225543","publication_url":"https://clinicaltrials.gov/study/NCT07225543","title":"Scavenging IsoLGs in Autoimmune Disease: a Proof-of-concept Clinical Study","has_exemption":false,"start_date":"2026-05-15","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07176546","publication_url":"https://clinicaltrials.gov/study/NCT07176546","title":"TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis","has_exemption":false,"start_date":"2026-05-22","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Robert Spiera, MD","sponsor_slug":"robert-spiera-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915233","publication_url":"https://clinicaltrials.gov/study/NCT06915233","title":"A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients With Symptomatic Chondral or Osteochondral Lesions of the Talus (MASCOT)","has_exemption":false,"start_date":"2026-05-28","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Vericel Corporation","sponsor_slug":"vericel-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07211802","publication_url":"https://clinicaltrials.gov/study/NCT07211802","title":"Utilizing Continuous Ketone Monitors to Enable Safe Use of SGLT Inhibitors in Patients With Type 1 Diabetes","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07470606","publication_url":"https://clinicaltrials.gov/study/NCT07470606","title":"Memory RT: Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain","has_exemption":false,"start_date":"2026-07-06","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07610369","publication_url":"https://clinicaltrials.gov/study/NCT07610369","title":"The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease","has_exemption":false,"start_date":"2026-07-10","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281768","publication_url":"https://clinicaltrials.gov/study/NCT07281768","title":"Combining Capecitabine/Oxaliplatin Chemotherapy With Cemiplimab Alone or in Combination With Fianlimab or REGN7075 for the Neoadjuvant Treatment of Locally Advanced Rectal Cancer","has_exemption":false,"start_date":"2026-07-14","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07556237","publication_url":"https://clinicaltrials.gov/study/NCT07556237","title":"Gastric Electrical Stimulation for Abdominal Pain in Patients With Gastroparesis","has_exemption":false,"start_date":"2026-07-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07770685","publication_url":"https://clinicaltrials.gov/study/NCT07770685","title":"A Phase 1, Multicenter, Open-Label, Ascending-Dose and Phase 2, Randomized, Double-Masked, Sham-Controlled, Clinical Study to Evaluate the Safety and Efficacy of ASP2767 in Participants With Optic Neuropathy Due to Glaucoma","has_exemption":false,"start_date":"2026-08-14","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07733466","publication_url":"https://clinicaltrials.gov/study/NCT07733466","title":"Neoadjuvant Pembrolizumab Plus Cetuximab in Betel Nut-Associated Locally Advanced Oral Cavity Squamous Cell Carcinoma in the Commonwealth of the Northern Mariana Islands: A Prospective, Open Label, Single Arm, Single Center, Non-randomized, Phase 2 Trial","has_exemption":false,"start_date":"2026-08-15","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Peter Brett, MD","sponsor_slug":"peter-brett-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07733908","publication_url":"https://clinicaltrials.gov/study/NCT07733908","title":"Efficacy of Posluma PET Scan in Evaulation and Monitoring of Patients Undergoing Focal Therapy for Prostate Cancer","has_exemption":false,"start_date":"2026-08-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Aditya Bagrodia","sponsor_slug":"aditya-bagrodia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07739966","publication_url":"https://clinicaltrials.gov/study/NCT07739966","title":"A Phase 1b/2, Multicenter, 2-part, Open-label Trial to Evaluate DS-3939a in Participants With Solid Tumors","has_exemption":false,"start_date":"2026-10-01","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07849114","publication_url":"https://clinicaltrials.gov/study/NCT07849114","title":"Deep Brain Stimulation of the Motor Thalamus Combined With Speech and Swallowing Therapy to Improve Post-Stroke Motor Speech and Swallowing Production Impairments","has_exemption":false,"start_date":"2027-01-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Pirondini, Elvira, PhD","sponsor_slug":"pirondini-elvira-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07137481","publication_url":"https://clinicaltrials.gov/study/NCT07137481","title":"Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies","has_exemption":false,"start_date":"2027-02-28","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07583641","publication_url":"https://clinicaltrials.gov/study/NCT07583641","title":"A Global, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult and Adolescent Participants With Autoimmune Encephalitis","has_exemption":false,"start_date":"2027-04-01","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02129751","publication_url":"https://clinicaltrials.gov/study/NCT02129751","title":"A Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder","has_exemption":false,"start_date":"2027-07-01","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07793461","publication_url":"https://clinicaltrials.gov/study/NCT07793461","title":"Gastrointestinal Dopamine Decarboxylase and Levodopa Pharmacokinetics","has_exemption":false,"start_date":"2027-07-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06443177","publication_url":"https://clinicaltrials.gov/study/NCT06443177","title":"The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage","has_exemption":false,"start_date":"2028-07-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215013","publication_url":"https://clinicaltrials.gov/study/NCT07215013","title":"Acoustic Resonance Therapy for Treatment of Empty Nose Syndrome: A Prospective, Phase 2 Randomized Clinical Trial","has_exemption":false,"start_date":"2028-07-31","completion_date":"2030-07-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05737693","publication_url":"https://clinicaltrials.gov/study/NCT05737693","title":"Posttraumatic Stress Disorder (PTSD) Treatment: Using Ketamine to Enhance Memory Reconsolidation and Extinction of Overgeneralized Fear in Individuals Diagnosed With PTSD","has_exemption":false,"start_date":"2023-08-21","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06467344","publication_url":"https://clinicaltrials.gov/study/NCT06467344","title":"ACDN-01-001: Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Subretinal ACDN-01 in Participants With ABCA4-related Retinopathy","has_exemption":false,"start_date":"2024-06-11","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"Ascidian Therapeutics, Inc","sponsor_slug":"ascidian-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06843551","publication_url":"https://clinicaltrials.gov/study/NCT06843551","title":"A Phase 2 Single Arm Trial of Stereotactic Body Radiation Therapy Followed by Dual Immune Checkpoint Inhibition for Patients With Metastatic Pancreatic Ductal Adenocarcinoma - The Miami \"EMPIRE\" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation","has_exemption":false,"start_date":"2025-06-18","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"Benjamin Spieler","sponsor_slug":"benjamin-spieler","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07516132","publication_url":"https://clinicaltrials.gov/study/NCT07516132","title":"A Phase 3b, Multicenter, Open-Label, Extension Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study","has_exemption":false,"start_date":"2026-04-27","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"Ocular Therapeutix, Inc.","sponsor_slug":"ocular-therapeutix-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06976840","publication_url":"https://clinicaltrials.gov/study/NCT06976840","title":"Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments","has_exemption":false,"start_date":"2026-05-15","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"Marta Peciña MD PhD","sponsor_slug":"marta-pecina-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06732388","publication_url":"https://clinicaltrials.gov/study/NCT06732388","title":"Repurposing Itraconazole for Secondary Prevention of Metaplasia and Primary Prevention of Cancer in Patients With High-risk Barrett's Esophagus in Combination With Ablation","has_exemption":false,"start_date":"2026-06-23","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07277595","publication_url":"https://clinicaltrials.gov/study/NCT07277595","title":"KTMP: A Novel Method of Non-invasive Brain Stimulation to Enhance Motor Function in Chronic Stroke Patients.","has_exemption":false,"start_date":"2026-07-01","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07532252","publication_url":"https://clinicaltrials.gov/study/NCT07532252","title":"A Double-Blind Randomized Controlled Trial of Daridorexant for Alcohol Use Disorder","has_exemption":false,"start_date":"2027-01-01","completion_date":"2030-08-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04047628","publication_url":"https://clinicaltrials.gov/study/NCT04047628","title":"A Multicenter Randomized Controlled Trial of Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis (ITN077AI)","has_exemption":false,"start_date":"2020-08-17","completion_date":"2030-08-06","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04976322","publication_url":"https://clinicaltrials.gov/study/NCT04976322","title":"A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirolizumab Pegol Treatment in Study Participants With Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2021-07-27","completion_date":"2030-08-07","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04300556","publication_url":"https://clinicaltrials.gov/study/NCT04300556","title":"A Multicenter, Open-Label Phase 1/2 Trial Evaluating the Safety, Tolerability, and Efficacy of MORAb-202, a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Subjects With Selected Tumor Types","has_exemption":false,"start_date":"2020-08-06","completion_date":"2030-08-08","has_results":false,"results_due":false,"sponsor_name":"Eisai Inc.","sponsor_slug":"eisai-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07768436","publication_url":"https://clinicaltrials.gov/study/NCT07768436","title":"STUDY OF DOSE DENSE CMF (Cyclophosphamide, Methotrexate, Fluorouracil) as an Alternative to AC (Doxorubicin, Cyclophosphamide) in 2 Regimens in EARLY STAGE BREAST CANCER for Patients Greater or Equal to 70","has_exemption":false,"start_date":"2026-08-11","completion_date":"2030-08-11","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06405087","publication_url":"https://clinicaltrials.gov/study/NCT06405087","title":"A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Subcutaneous in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease","has_exemption":false,"start_date":"2025-10-27","completion_date":"2030-08-12","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04579224","publication_url":"https://clinicaltrials.gov/study/NCT04579224","title":"A Phase III Randomized Trial of Eribulin (NSC #707389) With Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for, Anti PD1/PDL1 Therapy","has_exemption":false,"start_date":"2021-06-28","completion_date":"2030-08-15","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06683755","publication_url":"https://clinicaltrials.gov/study/NCT06683755","title":"Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)","has_exemption":false,"start_date":"2024-12-31","completion_date":"2030-08-16","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07436728","publication_url":"https://clinicaltrials.gov/study/NCT07436728","title":"A Phase 1/2 First-in-Human, Open-Label, Dose Escalation and Expansion Trial of TAK-505 Monotherapy in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2026-05-11","completion_date":"2030-08-18","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07851259","publication_url":"https://clinicaltrials.gov/study/NCT07851259","title":"A Phase II, Randomized, Double-Masked, Placebo-Controlled Multicenter Study to Assess the Efficacy and Safety of RO7965032 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration","has_exemption":false,"start_date":"2026-09-30","completion_date":"2030-08-21","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05983276","publication_url":"https://clinicaltrials.gov/study/NCT05983276","title":"Combination of the Hypomethylating Agent Decitabine and the Nuclear Export Receptor XPO-1 Inhibitor Selinexor to Reverse Platinum Resistance in Relapsed/Refractory Epithelial Ovarian Cancer","has_exemption":false,"start_date":"2023-11-16","completion_date":"2030-08-28","has_results":false,"results_due":false,"sponsor_name":"Loyola University","sponsor_slug":"loyola-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04877522","publication_url":"https://clinicaltrials.gov/study/NCT04877522","title":"An Open Label, Multi-center Asciminib Roll-over Study to Assess Long-term Safety in Patients Who Have Completed a Novartis Sponsored Asciminib Study and Are Judged by the Investigator to Benefit From Continued Treatment","has_exemption":false,"start_date":"2022-08-30","completion_date":"2030-08-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05451004","publication_url":"https://clinicaltrials.gov/study/NCT05451004","title":"SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer. A Phase III Randomized Controlled Trial","has_exemption":false,"start_date":"2023-02-10","completion_date":"2030-08-30","has_results":false,"results_due":false,"sponsor_name":"Canadian Cancer Trials Group","sponsor_slug":"canadian-cancer-trials-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07154706","publication_url":"https://clinicaltrials.gov/study/NCT07154706","title":"A Phase 3 Multicenter Double-blind Randomized Study of Taletrectinib Versus Placebo in Patients With ROS1-Fusion Positive Stage IB-IIIA Non-Small Cell Lung Cancer Who Have Undergone Complete Tumor Resection","has_exemption":false,"start_date":"2025-08-21","completion_date":"2030-08-30","has_results":false,"results_due":false,"sponsor_name":"Nuvation Bio, Inc.","sponsor_slug":"nuvation-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227311","publication_url":"https://clinicaltrials.gov/study/NCT07227311","title":"A Phase 2, Multicenter, Open Label, Non-randomized Study to Evaluate the Efficacy and Safety of Extended Dosing of Belantamab Mafodotin in Different Combinations With Standard of Care Regimens in Participants With Relapsed-refractory Multiple Myeloma (DREAMM-15)","has_exemption":false,"start_date":"2026-04-15","completion_date":"2030-08-30","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07652515","publication_url":"https://clinicaltrials.gov/study/NCT07652515","title":"Phase 4, Open Label, Single-arm, Interventional, Multicenter Study to Evaluate the Safety of Dostarlimab in Adult Patients in India With Primary Advanced or Recurrent Endometrial Cancer","has_exemption":false,"start_date":"2026-08-17","completion_date":"2030-08-30","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07079111","publication_url":"https://clinicaltrials.gov/study/NCT07079111","title":"3D Printed Occlusal Splints for Intraoperative Use","has_exemption":false,"start_date":"2026-12-30","completion_date":"2030-08-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03396276","publication_url":"https://clinicaltrials.gov/study/NCT03396276","title":"Houston Emergency Opioid Engagement System (HEROES)","has_exemption":false,"start_date":"2018-04-01","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03942328","publication_url":"https://clinicaltrials.gov/study/NCT03942328","title":"MC1641 Phase II Study Of Intratumoral Injection Of Autologous Dendritic Cells Combined With Immune Checkpoint Inhibition After High-Dose Conformal External Beam Radiotherapy In Patients With Unresectable Primary Liver Cancer","has_exemption":false,"start_date":"2019-09-19","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04110730","publication_url":"https://clinicaltrials.gov/study/NCT04110730","title":"The Influence of 3D Printed Prostheses on Neural Activation Patterns of the Primary Motor Cortex in Children With Unilateral Congenital Upper-limb Reductions","has_exemption":false,"start_date":"2020-01-10","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04811014","publication_url":"https://clinicaltrials.gov/study/NCT04811014","title":"Houston Emergency Engagement System for Youths and Adolescents","has_exemption":false,"start_date":"2021-04-19","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05092451","publication_url":"https://clinicaltrials.gov/study/NCT05092451","title":"Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances","has_exemption":false,"start_date":"2022-11-01","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06051617","publication_url":"https://clinicaltrials.gov/study/NCT06051617","title":"AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis","has_exemption":false,"start_date":"2023-09-07","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06431893","publication_url":"https://clinicaltrials.gov/study/NCT06431893","title":"An Open-Label, Phase 3 Long-Term Extension (LTE) Study To Assess The Safety, Tolerability, And Efficacy Of Treatment With Pegtibatinase In Participants With Classical Homocystinuria (HCU) Due To Cystathionine Beta Synthase Deficiency (ENSEMBLE)","has_exemption":false,"start_date":"2024-04-30","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Travere Therapeutics, Inc.","sponsor_slug":"travere-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219485","publication_url":"https://clinicaltrials.gov/study/NCT07219485","title":"An Open-Label Study to Evaluate Safety of Pitolisant in Participants With Prader-Willi Syndrome","has_exemption":false,"start_date":"2025-08-20","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Harmony Biosciences Management, Inc.","sponsor_slug":"harmony-biosciences-management-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06948019","publication_url":"https://clinicaltrials.gov/study/NCT06948019","title":"Safety and Efficacy of AAV9/AP4B1 For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47): A Phase 1/2 Single-Center, Open-Label Study of Stereotactic Intra-cisterna Magna Administration","has_exemption":false,"start_date":"2025-08-31","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"BlackfinBio Ltd","sponsor_slug":"blackfinbio-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07185256","publication_url":"https://clinicaltrials.gov/study/NCT07185256","title":"A Phase 1b/2a, Open-Label, Dose-Exploration Basket Study to Investigate the Safety and Tolerability of Subretinally Injected OPGx-BEST1 Administered in Patients With Either Autosomal-Dominant BEST1 Disease (Best Vitelliform Macular Dystrophy [BVMD]) or Autosomal-Recessive Bestrophinopathy (ARB)","has_exemption":false,"start_date":"2025-09-25","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Opus Genetics, Inc","sponsor_slug":"opus-genetics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07165028","publication_url":"https://clinicaltrials.gov/study/NCT07165028","title":"A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes","has_exemption":false,"start_date":"2025-10-15","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07303738","publication_url":"https://clinicaltrials.gov/study/NCT07303738","title":"The Use of High Bile-Binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations: A Novel Intervention for Children at Risk for Aspiration-Associated Complications (Aim 1)","has_exemption":false,"start_date":"2025-12-01","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07096297","publication_url":"https://clinicaltrials.gov/study/NCT07096297","title":"A Phase II Study of Luspatercept Plus Darbepoetin Alfa in Non-mutated SF3B1 Lower-risk Myelodysplastic Syndromes","has_exemption":false,"start_date":"2025-12-16","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07397559","publication_url":"https://clinicaltrials.gov/study/NCT07397559","title":"Spatiotemporal Control of Transcutaneous Spinal Cord Stimulation for Motor Function in SCI","has_exemption":false,"start_date":"2026-01-19","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07022405","publication_url":"https://clinicaltrials.gov/study/NCT07022405","title":"Stratified Pharmacological Approaches for Regulating Circuit-Level Effects Study","has_exemption":false,"start_date":"2026-01-23","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07029529","publication_url":"https://clinicaltrials.gov/study/NCT07029529","title":"Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder","has_exemption":false,"start_date":"2026-05-12","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07434492","publication_url":"https://clinicaltrials.gov/study/NCT07434492","title":"Smart Ankle-Foot Orthosis and 5-Azacitidine to Enhance Gait and Community Mobility for Children With Cerebral Palsy","has_exemption":false,"start_date":"2026-05-28","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Shirley Ryan AbilityLab","sponsor_slug":"shirley-ryan-abilitylab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07598643","publication_url":"https://clinicaltrials.gov/study/NCT07598643","title":"Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1","has_exemption":false,"start_date":"2026-05-28","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07450677","publication_url":"https://clinicaltrials.gov/study/NCT07450677","title":"Neurobehavioral Effects of Visual Assistive Technologies","has_exemption":false,"start_date":"2026-06-01","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07695701","publication_url":"https://clinicaltrials.gov/study/NCT07695701","title":"An Open-Label Study to Investigate the Long-Term Effects of Acoramidis on Cardiac Function, Structure and Cardiac Amyloid Burden in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)","has_exemption":false,"start_date":"2026-07-31","completion_date":"2030-08-31","has_results":false,"results_due":false,"sponsor_name":"Eidos Therapeutics, a BridgeBio company","sponsor_slug":"eidos-therapeutics-a-bridgebio-company","status":"ongoing","is_pact":false,"days_late":null}]}